EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients

Ning Zhu, Daibing Zhou, Wanfeng Xiong, Xiujuan Zhang, Shengqing Li

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1271853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Ning Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnosis of invasive pulmonary aspergillosis (IPA) diseases in non-neutropenic patients remains challenging. It is essential to develop optimal non-invasive or minimally invasive detection methods for the rapid and reliable diagnosis of IPA. Metagenomic next-generation sequencing (mNGS) in bronchoalveolar lavage fluid (BALF) can be a valuable tool for identifying the microorganism. Our study aims to evaluate the performance of mNGS in BALF in suspected IPA patients and compare it with other detection tests, including serum/BALF galactomannan antigen (GM) and traditional microbiological tests (BALF fungal culture and smear and lung biopsy histopathology). Ninety-four patients with suspicion of IPA were finally enrolled in our study. Thirty-nine patients were diagnosed with IPA, and 55 patients were non-IPA. There was significance between the IPA and non-IPA groups, such as BALF GM ( P < 0.001), history of glucocorticoid use ( P = 0.004), and pulmonary comorbidities ( P = 0.002), as well as no significance of the other demographic data including age, sex, BMI, history of cigarette, blood GM assay, T-SPOT.TB, and NEUT#/LYMPH#. The sensitivity of the BALF mNGS was 92.31%, which was higher than that of the traditional tests or the GM assays. The specificity of BALF mNGS was 92.73%, which was relatively similar to that of the traditional tests. The AUC of BALF mNGS was 0.925, which presented an excellent performance compared with other traditional tests or GM assays. Our study demonstrated the important role of BALF detection by the mNGS platform for pathogen identification in IPA patients with non-neutropenic states, which may provide an optimal way to diagnose suspected IPA disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisHumansBronchoalveolar Lavage FluidSensitivity and SpecificityLungHigh-Throughput Nucleotide SequencingRetrospective Studies

Stichwörter der Autor:innen

bronchoalveolar lavage fluiddiagnosisinvasive pulmonary aspergillosismetagenomic next-generation sequencingtraditional tests

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Zitieren

APA

Zhu, N., Zhou, D., Xiong, W., Zhang, X., & Li, S. (2023). Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1271853

Vancouver

Zhu N, Zhou D, Xiong W, Zhang X, Li S. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1271853

BibTeX
@article{Zhu2023,
  author = {Zhu, Ning and Zhou, Daibing and Xiong, Wanfeng and Zhang, Xiujuan and Li, Shengqing},
  title = {Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1271853}
}
Kostenlos starten →